Stephen Kent
University of Melbourne, VIC, Australia
Professor Kent trained as an infectious diseases physician, immunologist and HIV vaccine scientist in Melbourne and the USA. As a physician-scientist he is national leader in developing and testing HIV vaccines and is internationally recognised in this important field. He developed and manages a biologically secure facility to test promising HIV vaccines, one of very few in the Southern hemisphere. Vaccine concepts tested in recent years have shown sufficient promise to progress into human clinical trials.
Presentations this author is a contributor to:
Robust and prototypical immune responses towards COVID-19 BNT162b2 vaccine in First Nations Australian people are impacted by co-morbidities (#19)
11:20 AM
Katherine Kedzierska
Session 6: Pandemic Preparedness I
Robust SARS-CoV-2 T cell immunity towards COVID-19 vaccines in haematology patients of varying malignancies and immunosuppressive treatment (#174)
8:00 PM
Oanh Nguyen
Poster Session II
Lasting first impression: Ancestral imprinting restricts salivary antibody responses during Omicron breakthroughs (#146)
8:00 PM
Kevin John Selva
Poster Session II